default author photo

Stephan Ludwig

University of Münster

Universitätsstraße 14-16

Münster, 48143

Germany

SCHOLARLY PAPERS

3

DOWNLOADS

257

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Antiviral and Immunomodulatory Effect of Zapnometinib in Animal Models and Hospitalized COVID-19 Patients

Number of pages: 59 Posted: 14 Dec 2023
University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen, Atriva Therapeutics GmbH, Atriva Therapeutics GmbH, SIGNATOPE GmbH, SIGNATOPE GmbH, SIGNATOPE GmbH, Utrecht University, Utrecht University - Division of Pathology, Cerba Research Company, Cerba Research Company, University of Münster, University of Münster and University of Tübingen
Downloads 160 (467,092)

Abstract:

Loading...

zapnometinib, MEK inhibitor, host targeting agent, COVID-19, drug development, broad-spectrum antiviral

2.

The Host-Targeted Antiviral Drug Zapnometinib Does Not Induce Reduced Susceptibility of SARS-CoV-2

Number of pages: 29 Posted: 26 Jan 2024
University of Muenster, University of Muenster, University of Muenster, University of Muenster, University of Muenster, University of Muenster, University of Tübingen and University of Münster
Downloads 63 (933,592)

Abstract:

Loading...

SARS-CoV-2, Zapnometinib, host-targeted antiviral, direct-acting antiviral, drug resistance

3.

Antiviral Activity Against Hsv-1 of Triterpene Saponins from Anagallis Arvensis Is Related to the Fusion-Inhibitory Activity of Desglucoanagalloside B

Number of pages: 36 Posted: 18 Dec 2024
University of Münster, University of Münster, University of Münster, University of Münster, University of Münster, University of Münster, Free University of Berlin, University of Münster, Free University of Berlin, University of Münster and University of Münster
Downloads 34 (1,263,436)

Abstract:

Loading...

Anagallis arvensis, Herpes simplex virus, membrane fusion, plaque reduction, saponins, anagallosides